http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2002079466-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate | 2002-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2002079466-A1 |
| titleOfInvention | Genomic DNA involved in rheumatoid arthritis, a method for diagnosing the same, a method for determining the possibility of developing the same, and a diagnostic kit for detecting them |
| abstract | The present invention relates to genomic DNA having one or more of the following mutations in the genomic DNA of SEQ ID NO: 1, a method for diagnosing human rheumatoid arthritis using the mutations, a method for determining the possibility of onset thereof, and a diagnostic kit for detecting them. (1) Substitution of cytosine (c) to thymine (t) at the base of position 1987. (2) Substitution of the base at position 3664 from thymine (t) to guanine (g). (3) Substitution of the base at position 3769 from adenine (a) to cytosine (c). |
| priorityDate | 2001-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.